These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27777978)

  • 21. Using Klebsiella pneumoniae to Model Acute Lung Inflammation in Mice.
    McDaniel DK; Allen IC
    Methods Mol Biol; 2019; 1960():169-180. PubMed ID: 30798531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.
    Karaolis DK; Newstead MW; Zeng X; Hyodo M; Hayakawa Y; Bhan U; Liang H; Standiford TJ
    Infect Immun; 2007 Oct; 75(10):4942-50. PubMed ID: 17646358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing.
    Sutherland RE; Olsen JS; McKinstry A; Villalta SA; Wolters PJ
    J Immunol; 2008 Oct; 181(8):5598-605. PubMed ID: 18832718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate Immune Signaling Activated by MDR Bacteria in the Airway.
    Parker D; Ahn D; Cohen T; Prince A
    Physiol Rev; 2016 Jan; 96(1):19-53. PubMed ID: 26582515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspase-11 deficiency impairs neutrophil recruitment and bacterial clearance in the early stage of pulmonary Klebsiella pneumoniae infection.
    Wang J; Shao Y; Wang W; Li S; Xin N; Xie F; Zhao C
    Int J Med Microbiol; 2017 Dec; 307(8):490-496. PubMed ID: 28939441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.
    de Paula TP; Santos PC; Arifa RDDN; Vieira AT; Baltazar LM; Ávila TV; Fagundes CT; Garcia ZM; Lima RL; Teixeira MM; Souza DG
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population Structure of Klebsiella pneumoniae Causing Bloodstream Infections at a New York City Tertiary Care Hospital: Diversification of Multidrug-Resistant Isolates.
    Gomez-Simmonds A; Greenman M; Sullivan SB; Tanner JP; Sowash MG; Whittier S; Uhlemann AC
    J Clin Microbiol; 2015 Jul; 53(7):2060-7. PubMed ID: 25878348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ST258 isolated from a Japanese patient without a history of foreign travel - a new public health concern in Japan: a case report.
    Ainoda Y; Aoki K; Ishii Y; Okuda K; Furukawa H; Manabe R; Sahara T; Nakamura-Uchiyama F; Kurosu H; Ando Y; Fujisawa M; Hoshino H; Arima H; Ohnishi K
    BMC Infect Dis; 2019 Jan; 19(1):20. PubMed ID: 30616536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection.
    Deng JC; Zeng X; Newstead M; Moore TA; Tsai WC; Thannickal VJ; Standiford TJ
    J Immunol; 2004 Sep; 173(6):4075-83. PubMed ID: 15356157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase.
    Clemente AM; Castronovo G; Antonelli A; D'Andrea MM; Tanturli M; Perissi E; Paccosi S; Parenti A; Cozzolino F; Rossolini GM; Torcia MG
    PLoS One; 2017; 12(6):e0178847. PubMed ID: 28586386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Klebsiella pneumoniae FimK Promotes Virulence in Murine Pneumonia.
    Rosen DA; Hilliard JK; Tiemann KM; Todd EM; Morley SC; Hunstad DA
    J Infect Dis; 2016 Feb; 213(4):649-58. PubMed ID: 26347570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-33 improves local immunity during Gram-negative pneumonia by a combined effect on neutrophils and inflammatory monocytes.
    Ramirez-Moral I; Blok DC; Bernink JH; Garcia-Laorden MI; Florquin S; Boon L; Van't Veer C; Mack M; Saluzzo S; Knapp S; Spits H; de Vos AF; van der Poll T
    J Pathol; 2021 Apr; 253(4):374-383. PubMed ID: 33305354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258.
    Szijártó V; Guachalla LM; Hartl K; Varga C; Badarau A; Mirkina I; Visram ZC; Stulik L; Power CA; Nagy E; Nagy G
    Virulence; 2017 Oct; 8(7):1203-1215. PubMed ID: 28103139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae.
    Naparstek L; Carmeli Y; Chmelnitsky I; Banin E; Navon-Venezia S
    J Hosp Infect; 2012 May; 81(1):15-9. PubMed ID: 22463977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection.
    Deng JC; Moore TA; Newstead MW; Zeng X; Krieg AM; Standiford TJ
    J Immunol; 2004 Oct; 173(8):5148-55. PubMed ID: 15470059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia.
    Greenberger MJ; Strieter RM; Kunkel SL; Danforth JM; Laichalk LL; McGillicuddy DC; Standiford TJ
    J Infect Dis; 1996 Jan; 173(1):159-65. PubMed ID: 8537653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron Acquisition and Siderophore Release by Carbapenem-Resistant Sequence Type 258
    Holden VI; Wright MS; Houle S; Collingwood A; Dozois CM; Adams MD; Bachman MA
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669884
    [No Abstract]   [Full Text] [Related]  

  • 39. Genomic analysis of the first isolate of KPC-2-producing Klebsiella pneumoniae from Uruguay.
    Álvarez VE; Campos J; Galiana A; Borthagaray G; Centrón D; Márquez Villalba C
    J Glob Antimicrob Resist; 2018 Dec; 15():109-110. PubMed ID: 30213719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host immunology and rational immunotherapy for carbapenem-resistant Klebsiella pneumoniae infection.
    Iwanaga N; Sandquist I; Wanek A; McCombs J; Song K; Kolls JK
    JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32213713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.